Skip to content

Celcuity CELC Total Cash, Cash Equivalents, and Restricted Cash (Inclusive)

Total Cash, Cash Equivalents, and Restricted Cash (Inclusive) at other companies

Eli Lilly logo
Eli LillyLLY
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Tango Therapeutics logo
Tango TherapeuticsTNGX

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.4B+1,370%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's total cash, cash equivalents, and restricted cash (inclusive).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's total cash, cash equivalents, and restricted cash (inclusive)?
Celcuity (CELC) reported total cash, cash equivalents, and restricted cash (inclusive) of $145.19M in Q1 2026.
How has Celcuity's total cash, cash equivalents, and restricted cash (inclusive) changed year-over-year?
Celcuity's total cash, cash equivalents, and restricted cash (inclusive) increased by 781.1% year-over-year, from $16.48M to $145.19M.
What is the long-term trend for Celcuity's total cash, cash equivalents, and restricted cash (inclusive)?
Over 5 years (2020 to 2025), Celcuity's total cash, cash equivalents, and restricted cash (inclusive) has grown at a 70.1% compound annual growth rate (CAGR), from $11.64M to $165.7M.
What does total cash, cash equivalents, and restricted cash (inclusive) mean?
This represents the aggregate of all highly liquid assets, including cash, cash equivalents, and restricted cash balances, regardless of their classification in discontinued operations. It serves as the primary indicator of the company's immediate liquidity and its ability to fund ongoing research and development operations.